Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Pouget

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Pharmaceutics|July 2, 2021
Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right RadionuclideMalick Bio Idrissou, Alexandre Pichard, Bryan Tee, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2020
Synthesis and in vitro antitumour activity of carboplatin analogues containing functional handles compatible for conjugation to drug delivery systemsLisa-Maria Rečnik, Christophe Cantelli, Cyril Fersing, et al.
Immunotherapy|November 29, 2013
Tandem myeloablative 131I-rituximab radioimmunotherapy and high-dose chemotherapy in refractory/relapsed non-Hodgkin lymphoma patientsEmmanuel Deshayes, Françoise Kraeber-Bodéré, Jean-Philippe Vuillez, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|August 16, 2011
Assessment of the Stratos, a new pencil-beam bone densitometer: dosimetry, precision, and cross calibrationEnrique Nalda, Krishna Kunal Mahadea, Christophe Dematteï, et al.
International Journal of Radiation Biology|July 16, 2021
Rapid communication: insights into the role of extracellular vesicles during Auger radioimmunotherapyJihad Karam, Julie Constanzo, Alexandre Pichard, et al.
Nature Reviews. Clinical Oncology|November 9, 2011
Clinical radioimmunotherapy--the role of radiobiologyJean-Pierre Pouget, Isabelle Navarro-Teulon, Manuel Bardiès, et al.
Nuclear Medicine and Biology|March 12, 2014
DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapyBérengère Piron, Salomé Paillas, Vincent Boudousq, et al.
Molecules (Basel, Switzerland)|December 24, 2021
<i>In Silico</i> Investigation of the Biological Implications of Complex DNA Damage with Emphasis in Cancer Radiotherapy through a Systems Biology ApproachAthanasia Pavlopoulou, Seyedehsadaf Asfa, Evangelos Gioukakis, et al.
Nuclear Medicine and Biology|December 18, 2021
From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experienceJean-Pierre Pouget, Lore Santoro, Bérengère Piron, et al.
EJNMMI Research|December 1, 2018
Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [<sup>177</sup>Lu-[DOTA0, Tyr3]-octreotateLore Santoro, Erick Mora-Ramirez, Dorian Trauchessec, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Pharmaceutics|July 2, 2021
Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right RadionuclideMalick Bio Idrissou, Alexandre Pichard, Bryan Tee, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2020
Synthesis and in vitro antitumour activity of carboplatin analogues containing functional handles compatible for conjugation to drug delivery systemsLisa-Maria Rečnik, Christophe Cantelli, Cyril Fersing, et al.
Immunotherapy|November 29, 2013
Tandem myeloablative 131I-rituximab radioimmunotherapy and high-dose chemotherapy in refractory/relapsed non-Hodgkin lymphoma patientsEmmanuel Deshayes, Françoise Kraeber-Bodéré, Jean-Philippe Vuillez, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|August 16, 2011
Assessment of the Stratos, a new pencil-beam bone densitometer: dosimetry, precision, and cross calibrationEnrique Nalda, Krishna Kunal Mahadea, Christophe Dematteï, et al.
International Journal of Radiation Biology|July 16, 2021
Rapid communication: insights into the role of extracellular vesicles during Auger radioimmunotherapyJihad Karam, Julie Constanzo, Alexandre Pichard, et al.
Nature Reviews. Clinical Oncology|November 9, 2011
Clinical radioimmunotherapy--the role of radiobiologyJean-Pierre Pouget, Isabelle Navarro-Teulon, Manuel Bardiès, et al.
Nuclear Medicine and Biology|March 12, 2014
DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapyBérengère Piron, Salomé Paillas, Vincent Boudousq, et al.
Molecules (Basel, Switzerland)|December 24, 2021
<i>In Silico</i> Investigation of the Biological Implications of Complex DNA Damage with Emphasis in Cancer Radiotherapy through a Systems Biology ApproachAthanasia Pavlopoulou, Seyedehsadaf Asfa, Evangelos Gioukakis, et al.
Nuclear Medicine and Biology|December 18, 2021
From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experienceJean-Pierre Pouget, Lore Santoro, Bérengère Piron, et al.
EJNMMI Research|December 1, 2018
Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [<sup>177</sup>Lu-[DOTA0, Tyr3]-octreotateLore Santoro, Erick Mora-Ramirez, Dorian Trauchessec, et al.
Pageof 7